持田製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/05/24 | 5,270 | 5,330 | 5,240 | 5,320 | +70 | +1.3% | 36,200 |
2019/05/23 | 5,200 | 5,280 | 5,150 | 5,250 | +60 | +1.2% | 36,100 |
2019/05/22 | 5,230 | 5,260 | 5,170 | 5,190 | -40 | -0.8% | 31,800 |
2019/05/21 | 5,240 | 5,290 | 5,210 | 5,230 | ±0 | ±0% | 30,200 |
2019/05/20 | 5,280 | 5,310 | 5,220 | 5,230 | -40 | -0.8% | 34,500 |
2019/05/17 | 5,150 | 5,290 | 5,130 | 5,270 | +120 | +2.3% | 53,800 |
2019/05/16 | 4,955 | 5,170 | 4,950 | 5,150 | +225 | +4.6% | 73,500 |
2019/05/15 | 4,865 | 4,935 | 4,800 | 4,925 | -10 | -0.2% | 84,400 |
2019/05/14 | 4,755 | 5,020 | 4,620 | 4,935 | +145 | +3% | 178,900 |
2019/05/13 | 5,000 | 5,010 | 4,765 | 4,790 | -290 | -5.7% | 186,500 |
2019/05/10 | 5,110 | 5,220 | 5,040 | 5,080 | -30 | -0.6% | 94,200 |
2019/05/09 | 5,130 | 5,200 | 5,080 | 5,110 | -90 | -1.7% | 81,000 |
2019/05/08 | 5,100 | 5,220 | 5,050 | 5,200 | +40 | +0.8% | 73,200 |
2019/05/07 | 5,220 | 5,250 | 5,150 | 5,160 | ±0 | ±0% | 109,400 |
2019/04/26 | 5,190 | 5,230 | 5,130 | 5,160 | -20 | -0.4% | 37,900 |
2019/04/25 | 5,140 | 5,210 | 5,140 | 5,180 | -10 | -0.2% | 28,900 |
2019/04/24 | 5,280 | 5,310 | 5,180 | 5,190 | -20 | -0.4% | 35,100 |
2019/04/23 | 5,260 | 5,290 | 5,170 | 5,210 | -40 | -0.8% | 46,800 |
2019/04/22 | 5,170 | 5,270 | 5,090 | 5,250 | +70 | +1.4% | 32,400 |
2019/04/19 | 5,160 | 5,190 | 5,110 | 5,180 | +120 | +2.4% | 54,400 |
2019/04/18 | 5,200 | 5,220 | 5,050 | 5,060 | -200 | -3.8% | 59,000 |
2019/04/17 | 5,300 | 5,310 | 5,170 | 5,260 | -90 | -1.7% | 81,300 |
2019/04/16 | 5,500 | 5,530 | 5,300 | 5,350 | -180 | -3.3% | 55,200 |
2019/04/15 | 5,550 | 5,550 | 5,470 | 5,530 | +80 | +1.5% | 38,100 |
2019/04/12 | 5,600 | 5,600 | 5,440 | 5,450 | -80 | -1.4% | 42,800 |
2019/04/11 | 5,480 | 5,550 | 5,430 | 5,530 | +110 | +2% | 37,200 |
2019/04/10 | 5,430 | 5,460 | 5,390 | 5,420 | -30 | -0.6% | 58,400 |
2019/04/09 | 5,490 | 5,520 | 5,420 | 5,450 | -40 | -0.7% | 73,800 |
2019/04/08 | 5,490 | 5,560 | 5,460 | 5,490 | -20 | -0.4% | 42,600 |
2019/04/05 | 5,480 | 5,570 | 5,470 | 5,510 | ±0 | ±0% | 49,200 |
2019/04/04 | 5,670 | 5,670 | 5,480 | 5,510 | -180 | -3.2% | 64,300 |
2019/04/03 | 5,730 | 5,730 | 5,600 | 5,690 | -50 | -0.9% | 62,400 |
2019/04/02 | 5,940 | 6,000 | 5,680 | 5,740 | -140 | -2.4% | 137,100 |
2019/04/01 | 5,850 | 5,900 | 5,770 | 5,880 | +200 | +3.5% | 111,700 |
2019/03/29 | 5,640 | 5,740 | 5,600 | 5,680 | +70 | +1.2% | 92,200 |
2019/03/28 | 5,560 | 5,640 | 5,500 | 5,610 | -80 | -1.4% | 138,400 |
2019/03/27 | 5,780 | 5,800 | 5,610 | 5,690 | -5,720 | -50.1% | 183,400 |
2019/03/26 | 11,000 | 11,430 | 10,990 | 11,410 | +440 | +4% | 60,800 |
2019/03/25 | 10,950 | 11,100 | 10,870 | 10,970 | -100 | -0.9% | 54,000 |
2019/03/22 | 11,160 | 11,230 | 11,050 | 11,070 | -210 | -1.9% | 57,700 |
2019/03/20 | 11,270 | 11,330 | 11,130 | 11,280 | ±0 | ±0% | 51,500 |
2019/03/19 | 11,460 | 11,470 | 11,220 | 11,280 | -310 | -2.7% | 53,900 |
2019/03/18 | 11,580 | 11,620 | 11,490 | 11,590 | -30 | -0.3% | 47,900 |
2019/03/15 | 11,640 | 11,710 | 11,580 | 11,620 | -20 | -0.2% | 96,200 |
2019/03/14 | 11,970 | 11,970 | 11,640 | 11,640 | -290 | -2.4% | 48,200 |
2019/03/13 | 12,030 | 12,090 | 11,870 | 11,930 | -150 | -1.2% | 49,500 |
2019/03/12 | 12,000 | 12,110 | 11,950 | 12,080 | +140 | +1.2% | 54,100 |
2019/03/11 | 12,060 | 12,180 | 11,850 | 11,940 | -30 | -0.3% | 50,200 |
2019/03/08 | 12,170 | 12,220 | 11,960 | 11,970 | -200 | -1.6% | 70,300 |
2019/03/07 | 12,130 | 12,220 | 12,100 | 12,170 | +60 | +0.5% | 53,800 |
1501~
1550
件表示中 / 3740件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
持田薬 | 290,800円 | +5.1% | -7.0% | 2.75% | 19.09倍 | 0.79倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
サンバイオ | 216,600円 | - | - | 0.00% | - | 100.32倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
ゼリア新薬 | 205,100円 | +3.1% | -6.5% | 2.34% | 9.52倍 | 1.01倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
杏林製薬 | 150,000円 | -2.4% | -52.3% | 3.80% | 17.95倍 | 0.63倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ネクセラファーマ | 88,200円 | +20.3% | - | 0.00% | 156.38倍 | 1.16倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム